MBAL:CA:TSX-Mackenzie Balanced Allocation ETF (CAD)

ETF | Others |

Last Closing

CAD 24.83

Change

-0.07 (-0.28)%

Market Cap

CAD 0.09B

Volume

400.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

-0.01 (-0.01%)

CAD 5.37B
XEQT:CA iShares Core Equity Portfolio

+0.01 (+0.03%)

CAD 4.78B
PHYS-U:CA Sprott Physical Gold Trust

-0.11 (-0.54%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.11 (+0.30%)

CAD 4.54B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.28 (-1.13%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

N/A

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.08 (-0.35%)

CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

CAD 2.53B

ETFs Containing MBAL:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.00% 55% F 51% F
Dividend Return 1.65% 75% C 41% F
Total Return 13.65% 61% D- 52% F
Trailing 12 Months  
Capital Gain 19.49% 51% F 52% F
Dividend Return 2.77% 81% B- 47% F
Total Return 22.26% 56% F 53% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.25% N/A N/A 42% F
Dividend Return 1.47% N/A N/A 35% F
Total Return 0.22% N/A N/A 21% F
Risk Return Profile  
Volatility (Standard Deviation) 7.89% N/A N/A 56% F
Risk Adjusted Return 18.68% N/A N/A 41% F
Market Capitalization 0.09B 62% D 34% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike